The impact of renin-angiotensin-aldosterone system inhibitors on the recurrence of chronic subdural hematoma: a systematic review and meta-analysis

Nouri A, Gondar R, Schaller K, Meling T (2021) Chronic subdural hematoma (cSDH): a review of the current state of the art. Brain Spine 1:100300 Published 2021 Nov 2. https://doi.org/10.1016/j.bas.2021.100300

Article  PubMed  PubMed Central  Google Scholar 

Liu W, Bakker NA, Groen RJM (2014) Chronic subdural hematoma: a systematic review and meta-analysis of surgical procedures: a systematic review. J Neurosurg JNS 121(3):665–673. https://doi.org/10.3171/2014.5.JNS132715

Article  Google Scholar 

Adhiyaman V, Chattopadhyay I, Irshad F, Curran D, Abraham S (June 2017) Increasing incidence of chronic subdural haematoma in the elderly, QJM: an International Journal of Medicine. 110:375–378. https://doi.org/10.1093/qjmed/hcw231

El Rahal A, Beck J, Ahlborn P et al (2024) Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: A population-based Multicenter Cohort Study. Frontiers. June 19, 2023. Accessed May 27, https://www.frontiersin.org/journals/neurology/articles/https://doi.org/10.3389/fneur.2023.1206996/full

Cofano F, Pesce A, Vercelli G et al (2020) Risk of recurrence of chronic subdural hematomas after surgery: a Multicenter Observational Cohort Study. Front Neurol 11:560269 Published 2020 Nov 24. https://doi.org/10.3389/fneur.2020.560269

Article  PubMed  PubMed Central  Google Scholar 

Ma TK, Kam KK, Yan BP, Lam YY (2010) Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status. Br J Pharmacol 160(6):1273–1292. https://doi.org/10.1111/j.1476-5381.2010.00750.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

7, Rauhala M, Luoto TM, Huhtala H et al (2020) The incidence of chronic subdural hematomas from 1990 to 2015 in a defined Finnish population. J Neurosurg 132(4):1147–1157. https://doi.org/10.3171/2018.12.JNS183035

Article  Google Scholar 

Oh HJ, Lee KS, Shim JJ, Yoon SM, Yun IG, Bae HG (2010) Postoperative course and recurrence of chronic subdural hematoma. J Korean Neurosurg Soc 48(6):518–523. https://doi.org/10.3340/jkns.2010.48.6.518

Article  PubMed  PubMed Central  Google Scholar 

Stejskal P, Vaverka M, Trnka S, Hampl M, Hrabalek L (2021) Effect of angiotensin converting enzyme inhibitors on the development of chronic subdural haematoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 165(2):175–178

Article  PubMed  Google Scholar 

Shimohigoshi W, Takase H, Haze T, Kobayashi Y, Manaka H, Kawasaki T et al (2023) Renin-angiotensin-aldosterone system inhibitors as a risk factor for chronic subdural hematoma recurrence: A matter of debate. J Stroke Cerebrovasc Dis 32(10):107291

Article  PubMed  Google Scholar 

Bartek J, Sjåvik K, Schaible S, Gulati S, Solheim O, Förander P et al (2018) The role of angiotensin-converting enzyme inhibitors in patients with chronic subdural hematoma: a Scandinavian Population-based Multicenter Study. World Neurosurg 113:e555–e60

Article  PubMed  Google Scholar 

Neidert MC, Schmidt T, Mitova T, Fierstra J, Bellut D, Regli L et al (2016) Preoperative angiotensin converting enzyme inhibitor usage in patients with chronic subdural hematoma: associations with initial presentation and clinical outcome. J Clin Neurosci 28:82–86

Article  CAS  PubMed  Google Scholar 

Weigel R, Hohenstein A, Schlickum L, Weiss C, Schilling L, Angiotensin converting enzyme inhibition, for arterial hypertension reduces the risk of recurrence in patients with chronic subdural hematoma possibly by an antiangiogenic mechanism (2007). Neurosurgery. ;61(4)

Poulsen FR, Munthe S, Søe M, Halle B (2014) Perindopril and residual chronic subdural hematoma volumes six weeks after burr hole surgery: a randomized trial. Clin Neurol Neurosurg 123:48

Article  Google Scholar 

Stubbs DJ, Vivian ME, Davies BM, Ercole A, Burnstein R, Joannides AJ (2021) Incidence of chronic subdural haematoma: a single-centre exploration of the effects of an ageing population with a review of the literature. Acta Neurochir (Wien) 163(9):2629–2637. https://doi.org/10.1007/s00701-021-04879-z

Article  CAS  PubMed  Google Scholar 

Yadav YR, Parihar V, Namdev H, Bajaj J (2016) Chronic subdural hematoma. Asian J Neurosurg 11(4):330–342. https://doi.org/10.4103/1793-5482.145102

Article  PubMed  PubMed Central  Google Scholar 

Sadeghian H, Chida K, Motiei-Langroudi R, Editorial (2023) Chronic subdural hematoma: overview of recent therapeutic advancements. Front Neurol 14:1155680 Published 2023 Apr 3. https://doi.org/10.3389/fneur.2023.1155680

Article  PubMed  PubMed Central  Google Scholar 

Kim KH, Lee Y (2023) Medical Management of Chronic Subdural Hematoma. Korean J Neurotrauma 19(3):288–297 Published 2023 Sep 19. https://doi.org/10.13004/kjnt.2023.19.e47

Article  PubMed  PubMed Central  Google Scholar 

Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 14(1):108. Published 2017 May 30. https://doi.org/10.1186/s12974-017-0881-y

Motiei-Langroudi R, Stippler M, Shi S et al (2018) Factors predicting reoperation of chronic subdural hematoma following primary surgical evacuation. J Neurosurg JNS 129(5):1143–1150. https://doi.org/10.3171/2017.6.JNS17130

Article  CAS  Google Scholar 

Uno M (2023) Chronic subdural hematoma-evolution of etiology and surgical treatment. Neurol Med Chir (Tokyo) 63(1):1–8. https://doi.org/10.2176/jns-nmc.2022-0207

Article  PubMed  Google Scholar 

Weigel R, Schilling L, Krauss JK (2022) The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor. Geroscience 44(3):1353–1371. https://doi.org/10.1007/s11357-022-00570-y

Article  PubMed  PubMed Central  Google Scholar 

Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ (2017) Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 14(1):108. Published 2017 May 30. https://doi.org/10.1186/s12974-017-0881-y

Goodell CL, Mealey J Jr. (1963) Pathogenesis of chronic subdural hematoma. Experimental studies. Arch Neurol 8:429–437. https://doi.org/10.1001/archneur.1963.00460040099009

Article  CAS  PubMed  Google Scholar 

Tom B, Dendorfer A, de Vries R, Saxena PR, Jan Danser AH (2002) Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol 137(2):276–284. https://doi.org/10.1038/sj.bjp.0704862

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petrov A, Ivanov A, Dryagina N, Petrova A, Samochernykh K, Rozhchenko L (2022) Angiogenetic factors in chronic subdural Hematoma Development. Diagnostics (Basel) 12(11):2787. https://doi.org/10.3390/diagnostics12112787. Published 2022 Nov 14

Article  PubMed  Google Scholar 

Xiao P, Zhang Y, Zeng Y et al (2023) Impaired angiogenesis in ageing: the central role of the extracellular matrix. J Transl Med 21:457. https://doi.org/10.1186/s12967-023-04315-z

Article  PubMed  PubMed Central  Google Scholar 

Xian L, Wang C, Wang W et al (2021) The construction of an improved model of acute subdural hematoma in rats. J Neurosci Methods 351:109075. https://doi.org/10.1016/j.jneumeth.2021.109075

Article  CAS  PubMed  Google Scholar 

Comments (0)

No login
gif